Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
& Sugunan, S
If maintained properly, this patent would have expired in March 2026, but it expired in 2020 instead
Opportunities for Manufacturers in UMIC: How Price Reduction Can Drive Adoption Source: UMIC countries as per World Bank definition In price-sensitive markets, affordability not awareness is the dominant adoption gate for GLP-1 obesity therapies
Genistein more effectively increased bone formation markers such as bone-alkaline phosphatase (b-ALP) and decreased bone resorption markers like collagen C-telopeptide (CTX)
US$ 20.14
US$ 29.76
US$ 20.16
US$ 27.16
US$ 20.92
